VIDEO

FindCenter AddIcon

There Is No Such Thing as a “Bad Drug” | Psychedcast Ft. Mark Haden

By Mark Haden — 2020

Mark Haden is the executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada as well as an adjunct professor at the University of British Columbia School of Public and Population Health.

30:35 min

43:07

Bob Jesse: “Entheogens, Awakening, and Spiritual Development” | Horizons 2009

Profound experiences of non-dual consciousness sometimes lead to lasting, and lastingly beneficial, changes in values and behavior.

FindCenter AddIcon
07:41

Roland Griffiths: Psilocybin Research for Anxiety & Psychological Distress

FindCenter AddIcon
15:59

The Science of Psilocybin and Its Use to Relieve Suffering

Leading psychopharmacologist Roland Griffiths discloses the ways that psychedelic drugs can be used to create spiritually meaningful, personally transformative experiences for all patients, especially the terminally ill.

FindCenter AddIcon
47:46

Robert Jesse: Psilocybin Occasions Mystical Experiences Having Sustained Spiritual Significance

Robert Jesse is the organiser of the Council on Spiritual Practices, which aims to shift modernity's awareness and practices with respect to primary religious experience.

FindCenter AddIcon
01:09:33

Psychedelics Impact on Society | Rick Doblin, Ph.D. | Talks at Google

Rick Doblin - "Psychedelics: Mystical Experiences, Cultural Evolution, Non-Profit MDMA/PTSD Research, and Burning Man" Rick Doblin, the co-founder and CEO of the Multidisciplinary Association for Psychedelic Studies (MAPS, www.maps.

FindCenter AddIcon
15:59

Roland Griffiths - the Science of Psilocybin and Its Use to Relieve Suffering

The Hopkins laboratory has also conducted a recent series of internet survey studies characterizing the effects hallucinogen-occasioned mystical experiences, challenging experiences, and effects on substance abuse.

FindCenter AddIcon
06:48

Effects of Dose on Psilocybin Mystical Experiences and ‘Bad Trips’ | Roland Griffiths

FindCenter AddIcon
14:18

Roland Griffiths Compares Psilocybin and Meditation fMRI

FindCenter AddIcon
01:01:07

Roland Griffiths: Johns Hopkins Psilocybin Project - Implications for Spirituality & Therapeutics

A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.

FindCenter AddIcon
36:37

Psilocybin & Spirituality Roland Griffiths, PhD. Johns Hopkins Behavioral Pharmacology Research Unit

Roland R. Griffiths, Ph.D. is a psychopharmacologist who serves as a professor and research coordinator at the Johns Hopkins University School of Medicine. This interview was captured during the Psychedemia conference at the University of Pennsylvania in September 2012.

FindCenter AddIcon

EXPLORE TOPIC

Drug Policy